col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


67 Results       Page 1

 [1] 
Wiley: American Journal of Hematology
  original article Date Title Authors   All Authors
1 [GO] 2023―Jul―14 Low risk of relapse in aplastic anemia patients after SARS-CoV-2 omicron infection: A prospective NICHE cohort Lele Zhang, Jingyu Zhao, Ruonan Li, Hong Pan, Zhen Gao, Weiwang Li, et al. (+2)
2 [GO] 2023―Jul―06 Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study Boris Sorin, Léa Gaigne, Margaux Garzaro, Guillaume Moulis, Arthur Mageau, Carine Lopez, et al. (+18)
3 [GO] 2023―May―08 Kinetics of cellular and humoral immunogenicity and effectiveness of SARS-CoV -2 booster vaccination in hematologic neoplasms Moraima Jiménez, Candela Fernández-Naval, Víctor Navarro, Sandra Novoa, Mónica Martinez-Gallo, Daniel Medina, et al. (+17)
4 [GO] 2023―Mar―05 Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients Veronica Bordoni, Maddalena Casale, Valeria Maria Pinto, Rita Carsetti, Barbara Gianesin, Maria Rita Gamberini, et al. (+15)
5 [GO] 2022―Nov―13 SARS-CoV -2 mRNA vaccination of aplastic anemia patients is safe and effective C. R. Pothast, K. van Dijk, E. S. Pool, C. J. M. Halkes, M. H. M. Heemskerk, J. M.-L. Tjon
6 [GO] 2022―Oct―29 COVID-19 mRNA Vaccine associated Cerebral Venous Thrombosis: Rare Adverse Event or Coincidence? Bingwen Eugene Fan, Ryan Ruiyang Ling, Kollengode Ramanathan, Bernard Pui Lam Leung, Xin Rong Lim, Veerendra M. Chadachan, et al. (+3)
7 [GO] 2022―Oct―19 Predictors of impaired antibody response after SARS-CoV -2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multi-center observational study Yasuo Mori, Naoyuki Uchida, Takuya Harada, Yuta Katayama, Atsushi Wake, Hiromi Iwasaki, et al. (+20)
8 [GO] 2022―Sep―15 Increased CD8 T-cell immunity after COVID-19 vaccination in lymphoid malignancy patients lacking adequate humoral response: An immune compensation mechanism? Lara S. Boerenkamp, Cilia R. Pothast, Romy C. Dijkland, Kayleigh van Dijk, Gwendolyn N. Y. van Gorkom, Inge H. M. van Loo, et al. (+4)
9 [GO] 2022―Aug―18 Adoptive transfer of functional SARS-COV-2-specific immunity from donor graft to hematopoietic stem cell transplant recipients Corinna La Rosa, Flavia Chiuppesi, Yoonsuh Park, Ketevan Gendzekhadze, Qiao Zhou, Katelyn Faircloth, et al. (+10)
10 [GO] 2022―Jul―24 SARS-CoV -2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignancies Evangelos Terpos, Despina Fotiou, Vangelis Karalis, Ioannis Ntanasis-Stathopoulos, Aimilia D. Sklirou, Maria Gavriatopoulou, et al. (+5)
11 [GO] 2022―Jun―21 Neutrophil-Erythrocyte Rosettes in COVID-19 Bingwen Eugene Fan, Jia Qi Wendy Leong, Bernard Pui Lam Leung, Weng Yik Ng, Wendy Lim Siew Lian, Wei Yong Kevin Wong, et al. (+8)
12 [GO] 2022―Jun―15 Outcome of infection with omicron SARS-CoV -2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report Ola Blennow, Jon Salmanton-García, Piotr Nowak, Federico Itri, Jaap Van Doesum, Alberto López-García, et al. (+62)
13 [GO] 2022―May―24 Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV -2 variants, but preserved antigen-specific T cell responses Brendan Beaton, Sarah C. Sasson, Katherine Rankin, Juliette Raedemaeker, Alexander Wong, Priyanka Hastak, et al. (+15)
14 [GO] 2022―May―23 Vaccination does not affect leukocyte morphologic abnormalities of severe COVID-19 Gina Zini, Paola Arcuri, Rossella Ladiana, Eloisa Sofia Tanzarella, Gennaro De Pascale, Giuseppe d'Onofrio
15 [GO] 2022―Apr―26 A new diagnosis of monoclonal B-cell lymphocytosis with cytoplasmic inclusions in a patient with COVID-19 Lorella Lanza, Brisejda Koroveshi, Francesca Barducchi, Angela Lorenzo, Ezio Venturino, Enrico Cappelli, et al. (+2)
16 [GO] 2022―Mar―23 SARS-CoV -2 vaccination in patients with paroxysmal nocturnal hemoglobinuria: An Italian multicenter survey Juri Alessandro Giannotta, Bruno Fattizzo, Marta Bortolotti, Corrado Girmenia, Claudia Ielo, Elisabetta Metafuni, et al. (+10)
17 [GO] 2022―Jan―13 Third Dose of the BNT162b2 Vaccine Results in Very High Levels of Neutralizing Antibodies Against SARS-CoV -2; Results of a Prospective Study in 150 Health Professionals in Greece Evangelos Terpos, Vangelis Karalis, Aimilia D. Sklirou, Filia Apostolakou, Ioannis Ntanasis-Stathopoulos, Tina Bagratuni, et al. (+6)
18 [GO] 2022―Jan―11 BNT162b2 mRNA SARS-CoV -2 vaccination does not cause upregulation of endothelial activation markers or hypercoagulability: A Prospective, Single-Arm , Longitudinal Study Xin Rong Lim, Bernard Pui Lam Leung, Christina Lai Lin Sum, Gek Hsiang Lim, Choon Guan Chua, Tian Ming Tu, et al. (+4)
19 [GO] 2021―Dec―23 Increased blood viscosity and red blood cell aggregation in patients with COVID-19 Elie Nader, Christophe Nougier, Camille Boisson, Solene Poutrel, Judith Catella, Fiona Martin, et al. (+13)
20 [GO] 2021―Dec―03 Italian Patients With Hemoglobinopathies Exhibit A 5-Fold Increased in Age-Standardized Lethality Due To Sars-Cov-2 Infection Filomena Longo, Barbara Gianesin, Vincenzo Voi, Irene Motta, Valeria Maria, Andrea Piolatto, et al. (+48)
21 [GO] 2021―Dec―02 First and fatal case of autoimmune acquired Factor XIII/13 deficiency after COVID-19/SARS-CoV-2 vaccination Saori Shimoyama, Yuji Kanisawa, Kento Ono, Masayoshi Souri, Akitada Ichinose
22 [GO] 2021―Nov―22 Heterologous SARS-CoV -2 Vaccinations in Patients with B-cell Lymphoid Malignancies Chaitra Ujjani, Alexander L. Greninger, Mazyar Shadman, Joshua A. Hill, Ryan C. Lynch, Edus H. Warren, Ajay K. Gopal
23 [GO] 2021―Nov―15 Monotypic Plasmacytoid Cells Mimicking Lymph Node Malignancy in The Setting Of COVID-19 Recovery Mark G. Evans, Anthony Crymes, Jennifer L. Crombie, Sankha S. Basu, Deborah A. Dillon, Waihay J. Wong
24 [GO] 2021―Oct―25 SARS-CoV -2-reactive antibody detection after SARS-CoV -2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group ( GETH-TC ) José Luis Piñana, Lucia López-Corral, Rodrigo Martino, Juan Montoro, Lourdes Vazquez, Ariadna Pérez, et al. (+27)
25 [GO] 2021―Oct―21 Distinct Neutralization Profile of Spike Variants by Antibodies Induced upon SARS-CoV -2 Infection or Vaccination Margherita Rosati, Evangelos Terpos, Mahesh Agarwal, Vangelis Karalis, Jenifer Bear, Robert Burns, et al. (+7)
26 [GO] 2021―Oct―09 Platelet trends after Covid-19 vaccination in patients with chronic or persistent immune thrombocytopenia Debbie Jiang, Andrew Jay Portuguese, Amanda Weatherford, David Garcia, Terry Gernsheimer
27 [GO] 2021―Sep―15 Antibody Response to Covid-19 mRNA Vaccine (Comirnaty), in Myeloma Patients Treated with High-dose Melphalan and/or Immunotherapy Sandra Lockmer, Katarina Uttervall, Muhammad Kashif, Carina Svärd, Katarina Malmsten, Evellyn Fletcher-Torres, et al. (+3)
28 [GO] 2021―Sep―03 SARS-CoV -2 vaccination in patients with autoimmune cytopenias: the experience of a reference center Bruno Fattizzo, Juri Alessandro Giannotta, Nicola Cecchi, Wilma Barcellini
29 [GO] 2021―Aug―14 Serologic response to mRNA COVID-19 vaccination in lymphoma patients Eric M. Jurgens, Thomas J. Ketas, Zhen Zhao, Michael J. Satlin, Catherine B. Small, Ashley Sukhu, et al. (+10)
30 [GO] 2021―Jul―31 Impaired response to first SARS-CoV-2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib Paola Guglielmelli, Alessio Mazzoni, Laura Maggi, Seble Tekle Kiros, Lorenzo Zammarchi, Sofia Pilerci, et al. (+7)
31 [GO] 2021―Jun―16 Cerebral Venous Thrombosis post BNT162b2 mRNA SARS-CoV -2 vaccination: A Black Swan Event Bingwen Eugene Fan, Jia Yi Shen, Xin Rong Lim, Tian Ming Tu, Cheng Chieh Ray Chang, Hnin Su Wai Khin, et al. (+10)
32 [GO] 2021―May―31 SARS-CoV-2 vaccination induces breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria on complement inhibitor Bruno Fattizzo, Juri Alessandro Giannotta, Nicola Cecchi, Wilma Barcellini
33 [GO] 2021―May―24 Comparison of Neutralizing antibody responses against SARS-CoV -2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier? Evangelos Terpos, Ioannis P. Trougakos, Vangelis Karalis, Ioannis Ntanasis-Stathopoulos, Aimilia D. Sklirou, Tina Bagratuni, et al. (+6)
34 [GO] 2021―May―03 Hemolytic Crisis due to COVID-19 Vaccination in a Woman with Cold Agglutinin Disease Pérez-Lamas Lucía, Moreno-Jiménez Gemma, Tenorio-Núñez María Concepción, Velázquez-Kennedy Kyra, Jiménez-Chillón Carlos, Astibia-Mahillo Beatriz, et al. (+5)
35 [GO] 2021―Apr―29 Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy Rémy Duléry, Sylvain Lamure, Marc Delord, Roberta Di Blasi, Adrien Chauchet, Thomas Hueso, et al. (+19)
36 [GO] 2021―Apr―29 SARS-CoV -2 infection in patients with β-thalassemia: Experience from Lebanon Rayan Bou-Fakhredin, Hisham Daadaa, Suzanne Koussa, Therese Abou Nasr, Peter Noun, Ali T. Taher
37 [GO] 2021―Apr―10 Age- and gender-dependent antibody responses against SARS-CoV -2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine Evangelos Terpos, Ioannis P. Trougakos, Filia Apostolakou, Ioanna Charitaki, Aimilia D. Sklirou, Nefeli Mavrianou, et al. (+7)
38 [GO] 2021―Feb―13 Familial thrombocytopenia flare-up following the first dose of mRNA-1273 COVID-19 vaccine Sudhamshi Toom, Brian Wolf, Akshay Avula, Stephen Peeke, Kevin Becker
39 [GO] 2021―Jan―21 Immune Thrombocytopenia in a 22-Year-Old Post Covid-19 Vaccine Omar H. Tarawneh, Husam S. Tarawneh
40 [GO] 2021―Jan―15 Covid-19 and acute kidney injury Christina Crossette-Thambiah, Biswadip Hazarika, Barbara J. Bain
41 [GO] 2020―Dec―25 A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the COVID -19 pandemic Alexander H. Schmidt, Deborah Buk, Stefanie N. Bernas, Thilo Mengling, Elke Neujahr, Marcel R. M. van den Brink
42 [GO] 2020―Dec―02 COVID-19 will not “magically disappear”: Why Access to Widespread Testing is Paramount Paul E. George, Claire L. Stokes, Leda C. Bassit, Ann Chahroudi, Janet Figueroa, Mark A. Griffiths, et al. (+24)
43 [GO] 2020―Nov―18 Transplantation of Allogeneic Cryopreserved Hematopoietic Cell Grafts during the COVID-19 Pandemic: a National Marrow Donor Program Perspective Steven M. Devine
44 [GO] 2020―Oct―27 SFLT-1 LEVELS IN COVID-19 PATIENTS: ASSOCIATION WITH OUTCOME AND THROMBOSIS Aurelio Negro, Angelo Fama, Domenico Penna, Lucia Belloni, Alessandro Zerbini, Pasquale Gianluca Giuri
45 [GO] 2020―Oct―21 A Land in Agony: COVID-19, Economic Collapse, Political Corruption, and a Deadly Blast Antoine N. Saliba, Ali T. Taher
46 [GO] 2020―Oct―19 Hepcidin levels predict COVID-19 severity and mortality in a cohort of hospitalized Italian patients. Antonella Nai, Nicola Ivan Lorè, Alessia Pagani, Rebecca De Lorenzo, Simona Di Modica, Fabio Saliu, et al. (+4)
47 [GO] 2020―Oct―16 Association of ABO /Rh With SARS-CoV -2 Positivity: the Role of Race/Ethnicity in a Female Cohort Justin K. Niles, Hope E. Karnes, Jeffrey S. Dlott, Harvey W. Kaufman
48 [GO] 2020―Sep―24 Janus Family Kinase (JAK) Inhibitors in HLH and Severe COVID-19 Ryan A. Wilcox
49 [GO] 2020―Jul―13 Heparin induced thrombocytopenia antibodies in COVID-19 Rushad Patell, Adeel Khan, Thomas Bogue, Mwanasha Merrill, Anita Koshy, Poorva Bindal, et al. (+5)
50 [GO] 2020―May―30 Increased sFLT1/PlGF ratio in COVID-19: a novel link to Angiotensin II-mediated endothelial dysfunction Valentina Giardini, Andrea Carrer, Marco Casati, Ernesto Contro, Patrizia Vergani, Carlo Gambacorti-Passerini
51 [GO] 2020―May―16 The emergence of methemoglobinemia amidst the COVID -19 pandemic Leonard Naymagon, Shana Berwick, Alaina Kessler, Guido Lancman, Umesh Gidwani, Kevin Troy
52 [GO] 2020―May―13 The first case of acquired hemophilia A associated with SARS-CoV -2 infection Massimo Franchini, Claudia Glingani, Giuseppe De Donno, Salvatore Casari, Beatrice Caruso, Isabella Terenziani, et al. (+4)
53 [GO] 2020―May―12 Care of Patients with Hemoglobin Disorders during the COVID-19 Pandemic: An Overview of Recommendations Ali T. Taher, Rayan Bou-Fakhredin, Firas Kreidieh, Irene Motta, Lucia De Franceschi, Maria Domenica Cappellini
54 [GO] 2020―May―11 G6PD deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine M.T. Kuipers, R. Zwieten, J. Heijmans, C.E. Rutten, K. Heer, A.P. Kater, E. Nur
55 [GO] 2020―May―01 Dramatic improvement after Tocilizumab of a severe COVID-19 in a child with sickle cell disease and acute chest syndrome Marie-Hélène Odièvre, Charles Marcellus, Hubert Ducou Le Pointe, Slimane Allali, Anne Sophie Romain, Jenny Youn, et al. (+3)
56 [GO] 2020―May―01 Management of CLL Patients Early in the COVID-19 Pandemic: An International Survey of CLL Experts Brian Koffman, Anthony Mato, John C. Byrd, Alexey Danilov, Brad Hedrick, Chaitra Ujjani, et al. (+5)
57 [GO] 2020―Apr―27 Hematologic parameters in patients with COVID-19 infection Bingwen Eugene FAN
58 [GO] 2020―Apr―20 SARS-CoV -2 infection in beta thalassemia: preliminary data from the Italian experience. Irene Motta, Margherita Migone De Amicis, Valeria Maria Pinto, Manuela Balocco, Filomena Longo, Federico Bonetti, et al. (+6)
59 [GO] 2020―Apr―16 Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19) David Foldes, Richard Hinton, Siamak Arami, Barbara J. Bain
60 [GO] 2020―Apr―13 Hematological findings and complications of COVID-19 Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Ismail Elalamy, Efstathios Kastritis, Theodoros N. Sergentanis, Marianna Politou, et al. (+3)
61 [GO] 2020―Apr―13 Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab Gonzalo De Luna, Anoosha Habibi, Jean François Deux, Martin Colard, Anne Laure Pham Hung d'Alexandry d'Orengiani, Frédéric Schlemmer, et al. (+7)
62 [GO] 2020―Apr―12 Morphological anomalies of circulating blood cells in COVID-19 Gina Zini, Silvia Bellesi, Francesco Ramundo, Giuseppe d'Onofrio
63 [GO] 2020―Apr―12 Blood and blood product use during COVID-19 Infection Bingwen Eugene Fan, Kiat Hoe Ong, Stephrene Seok Wei Chan, Barnaby Edward Young, Vanessa Cui Lian Chong, Siew Ping Connie Chen, et al. (+3)
64 [GO] 2020―Apr―08 Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease due to 2019 Novel Coronavirus Disease (COVID-19) E. Nur, A.E. Gaartman, C.F.J. van Tuijn, M.W. Tang, B.J. Biemond
65 [GO] 2020―Apr―08 Critically Ill COVID-19 Infected Patients Exhibit Increased Clot Waveform Analysis Parameters Consistent with Hypercoagulability Chuen Wen Tan, Jenny Guek Hong Low, Wan Hui Wong, Ying Ying Chua, Sher Li Goh, Heng Joo Ng
66 [GO] 2020―Apr―03 COVID-19 Pneumonia as a Cause of Acute Chest Syndrome in an Adult Sickle Cell Patient Frans Beerkens, Mira John, Benjamin Puliafito, Virginia Corbett, Colleen Edwards, Douglas Tremblay
67 [GO] 2020―Mar―04 Hematologic parameters in patients with COVID-19 infection Bingwen Eugene Fan, Vanessa Cui Lian Chong, Stephrene Seok Wei Chan, Gek Hsiang Lim, Kian Guan Eric Lim, Guat Bee Tan, et al. (+3)
 [1] 

67 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.013 sec